PIONEER 5 The PIONEER 5 study enrolled patients with T2DM and moderate renal impairment (estimated glomerular filtration rate [eGFR] of 3059 mL/ min/1.73 m 2 ) to examine the efficacy and safety of oral semaglutide in patients with compromised kidney function
Participants consumed significantly more fat (% of total calories), saturated fat, linoleic acid, alpha-linolenic acid, selenium, sodium, riboflavin, niacin, and vitamin B12 than the DRI
Apply gentle pressure with a clean cotton ball or gauze
Supporting Customized Treatment Plans For patients receiving compounded semaglutide, mixing charts are particularly valuable as they support the creation of customized treatment plans
New medications, changes in eating patterns, or unusual stress can temporarily affect how you tolerate Retatrutide